Logo

People in the News: Apr 16, 2009

Apr 16, 2009
Premium

Santaris Pharma has appointed Arthur Levin, its chief development officer, as president of its new California-based subsidiary.

Levin previously served as vice president of drug development at Isis Pharmaceuticals. He holds a PhD in toxicology from the University of Rochester School of Medicine and Dentistry.

Filed under

Gene Silencing/Gene Editing
Drug Discovery & Development
RNAi
drug development
Isis
Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.